Division of GlaxoSmithKline PLC
Latest From GlaxoSmithKline Inc.
Five new OTC cough and cold products have hit the shelves in Germany this winter from Pari, Pohl Boskamp, Engelhard Arzneimittel, GSK and Dr Soldan.
Manufacturers say they might be penalized for violating program requirements that are yet to be established, since HRSA is issuing penalties rule first.
Candidate for first-approved LAMA/LABA combination for COPD heads to the Pulmonary-Allergy Drugs Advisory Committee as FDA questions whether safety is even a concern.
Medtronic and Johns Hopkins University’s Center for Bioengineering Innovation and Design are joining forces to develop medical devices for developing countries, starting in India, as part of a Medtronic grant.
- OTC, Consumer
- Therapeutic Areas
- Glaxo Canada Ltd.
- North America
- Parent & Subsidiaries
- GlaxoSmithKline PLC
- Senior Management
Paul N Lucas, Pres. & CEO
Sav DiPasquale, VP, Bus. Dev.
- Contact Info
Phone: (905) 819-3000
7333 Mississauga Rd. North
Mississauga, L5N 6L4
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.